ELAVL1 and neoplasm: Studies have shown that HuR promotes chronic inflammation by stabilizing TNF-α and IL-6 mRNAs and enhancing their expression within the tumor microenvironment (TME) (132, 146), thereby suppressing anti-tumor immune responses.